F3 and autoimmune polyendocrinopathy: In line with our findings, the authors concluded that INR reagents that utilized recombinant human thromboplastin were more sensitive to the presence of monoclonal and patient-derived antibodies with LA activity, consequently, APS patients positive for LA were suggested to be monitored using tissue-derived thromboplastin reagents.